Phoenix just notched a fresh bioscience win, with Taiwan-based JelloX Biotech choosing the city as its new U.S. beachhead and teaming up with Mayo Clinic at Discovery Oasis to bring AI-powered 3D pathology to town. The goal: help detect cancer earlier and with more precision. City leaders are pitching the move as another piece of a bigger strategy to lock in Phoenix as a serious hub for life-science startups and clinical research, arriving on the heels of ASU Health’s downtown groundbreaking that officials say will strengthen the region’s research and talent pipeline.
Phoenix’s continued strategic investment in the biosciences has put us on the map. 🧬 We just recruited Taiwan’s JelloX Biotech to partner with Mayo Clinic at Discovery Oasis, bringing AI-powered 3D pathology to detect cancer earlier and more precisely. 3/8
— Mayor Kate Gallego (@mayorgallego) April 21, 2026
What JelloX Brings
JelloX’s pitch to Phoenix is a 3D digital pathology platform that combines volumetric tissue imaging with machine learning in an effort to surface spatial biomarkers that conventional two-dimensional slides can miss, according to the company. The firm announced plans last year to open a U.S. research lab inside the Discovery Oasis biotech corridor, according to BioSpace, and reporting has noted U.S. regulatory clearances for the company’s MetaLite software, per Taiwan News.
Mayo Clinic Tie-Up
The Phoenix move builds on a JelloX know-how agreement with Mayo Clinic that was disclosed in 2024, a relationship intended to help validate the startup’s AI-enhanced 3D imaging for precision oncology. The original announcement also states that Mayo Clinic has a financial interest in the referenced technology, according to a company press release reported by PR Newswire.
Why Discovery Oasis Matters
Discovery Oasis is envisioned as a 120-acre biotechnology corridor wrapped around the Mayo Clinic hospital campus, set up to co-locate research labs, clinical partners and commercial life-science tenants. The development’s organizers say that clustering companies and clinical resources on a single campus is meant to speed up collaborations and commercialization, per materials on the Discovery Oasis website.
Local Impact And Next Steps
City and university officials argue that projects like JelloX’s lab and ASU Health’s new downtown headquarters will help create skilled jobs and keep translational research rooted in Phoenix instead of drifting to coastal markets. ASU marked a ceremonial groundbreaking for its 175,000-square-foot ASU Health building on April 9, and university leaders say the site will house a medical school, tech-for-public-health programs and facilities designed to train clinicians who can work at the intersection of medicine and AI, according to ASU News.
Mayor Kate Gallego has framed the JelloX recruitment as part of a long game to put Phoenix “on the map” for biosciences, highlighting the deal in a post on X. City officials say more tenant and partnership announcements are expected as Discovery Oasis fills out lab and office space and the campus edges closer to its biotech-corridor vision.
